Swiss National Bank Sells 7,600 Shares of Premier, Inc. (NASDAQ:PINC)

Swiss National Bank reduced its holdings in shares of Premier, Inc. (NASDAQ:PINC) by 3.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 197,112 shares of the company’s stock after selling 7,600 shares during the period. Swiss National Bank owned 0.21% of Premier worth $4,179,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of PINC. Brooklyn Investment Group boosted its position in shares of Premier by 61,750.0% in the 4th quarter. Brooklyn Investment Group now owns 1,237 shares of the company’s stock worth $26,000 after purchasing an additional 1,235 shares in the last quarter. SRS Capital Advisors Inc. raised its stake in Premier by 157.8% during the fourth quarter. SRS Capital Advisors Inc. now owns 1,284 shares of the company’s stock valued at $27,000 after buying an additional 786 shares during the last quarter. Keystone Financial Group Inc. bought a new stake in Premier in the fourth quarter worth $37,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Premier in the third quarter worth $39,000. Finally, Smartleaf Asset Management LLC increased its holdings in shares of Premier by 297.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,906 shares of the company’s stock valued at $40,000 after acquiring an additional 1,427 shares in the last quarter. Institutional investors own 74.41% of the company’s stock.

Insider Activity at Premier

In other Premier news, Director Helen M. Boudreau sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $21.42, for a total transaction of $53,550.00. Following the completion of the sale, the director now directly owns 20,668 shares of the company’s stock, valued at approximately $442,708.56. This represents a 10.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.96% of the stock is owned by company insiders.

Premier Trading Down 0.7 %

Shares of PINC stock opened at $18.95 on Wednesday. Premier, Inc. has a 12-month low of $17.23 and a 12-month high of $23.56. The stock has a market capitalization of $1.73 billion, a P/E ratio of -189.48 and a beta of 0.39. The firm’s 50 day moving average is $19.51 and its 200 day moving average is $20.49.

Premier Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Saturday, March 15th. Investors of record on Saturday, March 1st were issued a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 4.43%. The ex-dividend date was Friday, February 28th. Premier’s payout ratio is currently -840.00%.

Analyst Ratings Changes

PINC has been the subject of a number of analyst reports. Canaccord Genuity Group reduced their price objective on shares of Premier from $21.00 to $19.00 and set a “hold” rating for the company in a research note on Wednesday, February 5th. Piper Sandler decreased their price objective on shares of Premier from $21.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. Finally, Robert W. Baird lowered their price objective on Premier from $20.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Eight analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, Premier presently has a consensus rating of “Hold” and an average target price of $20.17.

Premier Company Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.